Yasuharu Nishimura

Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration

Ryuta Ishimura, Gábor Nagy, Iván Dotú et al. · Science · 2014 · 468 citations

Life Sciences, Molecular Biology, Neuroscience +17

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker

Tetsuya Nakatsura, Yoshihiro Yoshitake, Satoru Senju et al. · Biochemical and Biophysical Research Communications · 2003 · 432 citations

Medicine, Cancer Biology, Oncology +14

Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment

Hirotake Tsukamoto, Koji Fujieda, Azusa Miyashita et al. · Cancer Research · 2018 · 302 citations

Life Sciences, Immunology, Oncology +17

Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

Tetsuya Nakatsura, Toshiro Kageshita, Shosuke Ito et al. · Clinical Cancer Research · 2004 · 175 citations · Full text

Medicine, Oncology, Pathology +13

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju et al. · Clinical Cancer Research · 2006 · 174 citations

Life Sciences, Immunology, Oncology +15